David M. Gosky

Green Tea Constituent (−)-Epigallocatechin-3-gallate Inhibits Topoisomerase I Activity in Human Colon Carcinoma Cells

Sosamma J. Berger, Sanjay Gupta, Charles A. Belfi et al. · Biochemical and Biophysical Research Communications · 2001 · 105 citations

Oncology, Chemoprevention Strategy, Medicine +8

Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.

S J Berger, David M. Gosky, Elizabeth Zborowska et al. · PubMed · 1994 · 60 citations

Chemoprevention Strategy, Lipid Peroxidation, Metabolomic Profiling +17

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients

Chris H. Takimoto, Geraldine Morrison, Nancy Harold et al. · Journal of Clinical Oncology · 2000 · 57 citations

Increased Sensitivity of Human Colon Cancer Cells to DNA Cross-Linking Agents after GRP78 Up-Regulation

Charles A. Belfi, Satadal Chatterjee, David M. Gosky et al. · Biochemical and Biophysical Research Communications · 1999 · 48 citations

Oncology, Medicine, Colorectal Cancer +8

Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer

Afshin Dowlati, Nathan Levitan, Nahida H. Gordon et al. · Cancer Chemotherapy and Pharmacology · 2001 · 29 citations

Sequential Topoisomerase, Oncology, Phase Ii +8